Visceral Pain Market to 2024: Industry Capacity, Generation, Investment Trends, Regulations and Opportunities

The global visceral pain market is expected to reach USD 14.22 billion by 2024, driven by the increasing geriatric population globally. Increasing prevalence of visceral pain and rising awareness regarding the same is projected to drive market growth over the forecast period.

In 2016, North America held the majority of share in global visceral pain market owing to the increasing healthcare expenditure. Additionally, the high prevalence of Crohn’s and irritable bowel is expected to propel the growth of the market over the projected period.

Asia Pacific is expected to be the fastest growing region with the CAGR of 6.2%. The increase in the healthcare infrastructure and presence of a large pool of patients is projected to drive the demand for the visceral pain industry during the forecast period.

High therapy costs are likely to hinder the growth of the market. However, the costs are expected to reduce owing to various factors including production scales, intensive research & development of these drugs and government grants & subsidies. Lack of awareness in the society has been a challenge for the growth of the market over the past few years.

Key players analyzed:
• Pfizer Inc.
• Allergan
• Johnson & Johnson
• Bayer AG
• Takeda Pharmaceutical Company Limited
• Mallinkrodt Pharmaceuticals
• AbbVie Inc.
• AstraZeneca

Browse Details of Report @ https://www.hexaresearch.com/research-report/visceral-pain-market

Moreover, companies are focusing on R&D to expand the utilization of different raw materials such as PBS, PLA, and PBAT in various mainstream packaging applications. For instance, in April 2017, UK-based Biome Bioplastics developed a fully compostable and recyclable coffee cup made entirely from bioplastic materials. These factors together are expected to provide an impetus to the growth of the bioplastic packaging market over the next seven years.

PET dominated the global market contributing to USD 1.84 billion in 2016. The polymer was extensively used in rigid packaging on account of its high durability, transparency, and ease of moldability. Initiatives undertaken by companies such as Coca-Cola, P&G, and Heinz to use bio-based materials for packing beverages, sauces & spreads and cosmetics is expected to bolster the growth of the rigid packaging market.

Increasing demand for flexible packaging solutions on account of several benefits including size and weight particularly in food applications coupled with rising demand for biodegradable films is anticipated to boost the growth of the market. The segment is expected to grow at a volume CAGR of 20.6% from 2017 to 2024.

Food packaging accounted for 9% of the overall market share in 2016 and is likely to witness above average growth as a result of rising consumer requirement for eco-friendly packaging. Aesthetic attributes such as transparency, size, weight and presentation are expected to drive the growth of the segment over the projected period.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.